Literature DB >> 3018091

Human monkeypox: a study of 2,510 contacts of 214 patients.

Z Jezek, S S Marennikova, M Mutumbo, J H Nakano, K M Paluku, M Szczeniowski.   

Abstract

A study of 2,510 contacts of 214 patients with human monkeypox was conducted in Zaire from 1980 to 1984. Among the contacts of 130 primary cases of human monkeypox, a further 22 co-primary and 62 secondary cases were detected, and an additional fourteen people who had no evidence of clinical disease had positive serological results. A majority of the clinical and subclinical cases of monkeypox occurred in children less than 10 years of age. Immunity in vaccinated persons now appears to be waning because 16 overt cases occurred in contacts who had been vaccinated. The overall attack rate for contacts without a vaccination scar (7.2%) differed significantly from the attack rate for those who had been vaccinated in the past (0.9%). The attack rate for household contacts was significantly higher than that for other contacts, among both unvaccinated (four times higher) and vaccinated (seven times higher) household contacts. Many unvaccinated contacts living in the same household as the index case under conditions of maximum exposure, however, escaped not only the disease but also infection.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3018091     DOI: 10.1093/infdis/154.4.551

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  38 in total

1.  Optimization of peptide-based ELISA for serological diagnostics: a retrospective study of human monkeypox infection.

Authors:  Melissa E Dubois; Erika Hammarlund; Mark K Slifka
Journal:  Vector Borne Zoonotic Dis       Date:  2012-01-04       Impact factor: 2.133

Review 2.  Smallpox and its post-eradication surveillance.

Authors:  Z Jezek; L N Khodakevich; J F Wickett
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

Review 3.  Human poxvirus infection after the eradication of smallpox.

Authors:  D Baxby
Journal:  Epidemiol Infect       Date:  1988-06       Impact factor: 2.451

Review 4.  Whither monkeypox vaccination.

Authors:  Anne W Rimoin; Barney S Graham
Journal:  Vaccine       Date:  2011-12-19       Impact factor: 3.641

5.  Comparative evaluation of the immune responses and protection engendered by LC16m8 and Dryvax smallpox vaccines in a mouse model.

Authors:  Clement A Meseda; Anne E Mayer; Arunima Kumar; Alonzo D Garcia; Joseph Campbell; Paul Listrani; Jody Manischewitz; Lisa R King; Hana Golding; Michael Merchlinsky; Jerry P Weir
Journal:  Clin Vaccine Immunol       Date:  2009-07-15

6.  Smallpox inhibitor of complement enzymes (SPICE): regulation of complement activation on cells and mechanism of its cellular attachment.

Authors:  M Kathryn Liszewski; Paula Bertram; Marilyn K Leung; Richard Hauhart; Lijuan Zhang; John P Atkinson
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

7.  Enhancing health care worker ability to detect and care for patients with monkeypox in the Democratic Republic of the Congo.

Authors:  Jennifer Bass; Danielle M Tack; Andrea M McCollum; Joelle Kabamba; Elisabeth Pakuta; Jean Malekani; Beatrice Nguete; Benjamin P Monroe; Jeffrey B Doty; Stomy Karhemere; Inger K Damon; Marcel Balilo; Emile Okitolonda; Robert L Shongo; Mary G Reynolds
Journal:  Int Health       Date:  2013-11-17       Impact factor: 2.473

Review 8.  Poxvirus homologues of cellular genes.

Authors:  J J Bugert; G Darai
Journal:  Virus Genes       Date:  2000       Impact factor: 2.198

Review 9.  Qualitative assessment of risk for monkeypox associated with domestic trade in certain animal species, United States.

Authors:  Susan M Bernard; Steven A Anderson
Journal:  Emerg Infect Dis       Date:  2006-12       Impact factor: 6.883

10.  Spectrum of infection and risk factors for human monkeypox, United States, 2003.

Authors:  Mary G Reynolds; Whitni B Davidson; Aaron T Curns; Craig S Conover; Gregory Huhn; Jeffrey P Davis; Mark Wegner; Donita R Croft; Alexandra Newman; Nkolika N Obiesie; Gail R Hansen; Patrick L Hays; Pamela Pontones; Brad Beard; Robert Teclaw; James F Howell; Zachary Braden; Robert C Holman; Kevin L Karem; Inger K Damon
Journal:  Emerg Infect Dis       Date:  2007-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.